SO
66
2
LYB
46
-4
VMC
57
-3
DHR
56
-4
USB
44
-3
PSA
66
3
SWN
77
4
FIS
46
-4
PCAR
50
-3
LB
38
-7
SJM
38
-3
PPL
65
6
SIG
57
-3
KHC
59
14
MDLZ
65
-2
TROW
34
-5
TXT
58
-2
BIIB
37
7
MS
64
7
SWKS
38
-2
SO
66
2
LYB
46
-4
VMC
57
-3
DHR
56
-4
USB
44
-3
PSA
66
3
SWN
77
4
FIS
46
-4
PCAR
50
-3
LB
38
-7
SJM
38
-3
PPL
65
6
SIG
57
-3
KHC
59
14
MDLZ
65
-2
TROW
34
-5
TXT
58
-2
BIIB
37
7
MS
64
7
SWKS
38
-2
Financhill
Back

Sarepta Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
41

SRPT
Sarepta Therapeutics

Last Price:
127.17
Seasonality Move:
0.19%
Sell
40

ALNY
Alnylam Pharmaceuticals

Last Price:
273.83
Seasonality Move:
3.21%
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $127.17. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $273.88. The Score for ALNY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $127.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $273.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight buying pressure.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.52 Sell
Relative Strength Index (14 RSI): 38.9 Sell
Chaikin Money Flow: 50230 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (126.71 - 139.27) Sell
Bollinger Bands (100): (124.42 - 147.62) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.42 Buy
Relative Strength Index (14 RSI): 58.09 Buy
Chaikin Money Flow: 377648 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (257.34 - 278.94) Buy
Bollinger Bands (100): (166.06 - 270.8) Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.97 Buy
20-day SMA: 131.43 Sell
50-day SMA: 137.6 Sell
200-day SMA: 126.61 Buy
8-day EMA: 126.89 Buy
20-day EMA: 130.12 Sell
50-day EMA: 134.31 Sell
200-day EMA: 128.83 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 269.63 Buy
20-day SMA: 266.18 Buy
50-day SMA: 260.04 Buy
200-day SMA: 192.17 Buy
8-day EMA: 270.19 Buy
20-day EMA: 266.62 Buy
50-day EMA: 254.32 Buy
200-day EMA: 208.68 Buy

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):